Vaginal Gel Cuts Women’s HIV Risk

Scientists are hailing a new vaginal gel as a breakthrough in the fight against HIV infection. Use of the gel cut in half a woman’s risk of being infected by a sex partner. The gel contains the drug tenofovir. This drug also is used to treat AIDS, the disease caused by HIV. The study included 889 heterosexual women in South Africa. They did not have HIV infection when the study started. Half of them were given the gel and told how to use it before and after sex. The other women received the same instructions, but a different gel. This gel was a placebo. It had no medicine in it. The researchers did not know which women got which gel. Neither did the women. After one year, the HIV infection rate in those who got the real drug was reduced by 50%, compared with women who got the placebo. After 2½ years, the rate was reduced by 39%. The journal Science published the study online.